ALK gene rearrangement |
View Test |
BCR-ABL1 t(9;22)(q34;q11) Diagnostic (for suspected CML) |
View Test |
BCR-ABL1 t(9;22)(q34;q11) E1A2, E13A2 & E14A2 transcripts Diagnostic Acute Leukaemia |
View Test |
BRAF mutation analysis |
View Test |
CBFB-MYH11 inv(16) / t(16;16) Diagnostic (AML) |
View Test |
DPYD Genotyping |
View Test |
EGFR mutation analysis (blood) |
View Test |
EGFR mutation analysis (FFPE) |
View Test |
ETV6-RUNX1 t(12;21)(p13;q22) Diagnostic (ALL) |
View Test |
FIP1L1-PDGFRA fusion gene |
View Test |
FLT3 |
View Test |
FOXL2 mutation analysis |
View Test |
HER2 gene amplification |
View Test |
IDH1 and IDH2 mutation analysis |
View Test |
Immunoglobulin HV Gene Sequencing |
View Test |
KIT and PDGFRA mutation analysis |
View Test |
KIT D816V Mutation Testing |
View Test |
KMT2A (MLL, 11q23) rearrangement Diagnostic test for Acute Leukaemia |
View Test |
KRAS mutation analysis |
View Test |
MGMT promoter methylation analysis |
View Test |
Mismatch repair testing |
View Test |
MRD monitoring for BCR-ABL1 E13A2 and/or E14A2 transcripts |
View Test |
MRD monitoring for BCR-ABL1 E1A2 transcript |
View Test |
Next Generation Sequencing (NGS) for Myeloid Disorders |
View Test |
NPM1 |
View Test |
NRAS mutation analysis |
View Test |
PD-L1 immunohistochemistry |
View Test |
PML-RARA t(15;17)(q22;q21) Diagnostic (AML) |
View Test |
ROS1 gene rearrangement |
View Test |
RUNX1-RUNX1T1 t(8:21)(q22;q22) Diagnostic (AML) |
View Test |
TCF3-PBX1 t(1;19)(q23;p13) Diagnostic (ALL) |
View Test |
TCR Gene Clonality |
View Test |
TP53 |
View Test |